Alto Neuroscience (ANRO) Treasury Shares (2024 - 2025)
Alto Neuroscience's (ANRO) quarterly Treasury Shares came in at $27000.0 in Q4 2025, down 50.0% year-on-year from $54000.0 in Q4 2024, and little changed quarter-over-quarter from $27000.0 in Q3 2025.
Alto Neuroscience (ANRO) Treasury Shares (2024 - 2025) Analysis & Trends
Alto Neuroscience has disclosed Treasury Shares across 2 years of filings, most recently posting $27000.0 for Q4 2025.
- Treasury Shares for Q4 2025 came in at $27000.0, down 50.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $27000.0 (down 50.0% YoY), and the FY2025 annual result was $27000.0, down 50.0% from the prior year.
- Treasury Shares came in at $27000.0 for Q4 2025 at Alto Neuroscience, roughly flat from $27000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $592748.0 in Q1 2024 to a low of $27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 592,748.00 |
| Mar 31, 2024 | 592,748.00 |